We observed the absence of ID8 signature in our post-radiation RRD-HGG tumor specimens after treatment with anti–PD-1 monotherapy as compared with previously published post-radiation non-RRD glioma controls not treated with ICI (ref. 42; Fig. 5D). Here, PDCD1 is linked to central nervous system cancer.